284 related articles for article (PubMed ID: 19485297)
1. Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy.
Kim SW; Oh J; Oh IK; Huh K
Ophthalmic Surg Lasers Imaging; 2009; 40(3):300-3. PubMed ID: 19485297
[TBL] [Abstract][Full Text] [Related]
2. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
[TBL] [Abstract][Full Text] [Related]
4. PHOTODYNAMIC THERAPY FOR SYMPTOMATIC SUBFOVEAL RETINAL PIGMENT EPITHELIAL DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: Outcomes and Prognostic Factors.
Hwang S; Kang SW; Kim SJ; Jang JW; Kim KT
Retina; 2019 Jun; 39(6):1117-1124. PubMed ID: 29517581
[TBL] [Abstract][Full Text] [Related]
5. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
Matušková V; Vysloužilová D; Uher M
Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
[TBL] [Abstract][Full Text] [Related]
6. Giant retinal pigment epithelial tear following photodynamic therapy for the bullous variant of central serous chorioretinopathy: A case report.
Kimura E; Miura M
Medicine (Baltimore); 2024 Apr; 103(16):e37855. PubMed ID: 38640292
[TBL] [Abstract][Full Text] [Related]
7. Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability.
Goto S; Gomi F; Ueno C; Nishida K
Am J Ophthalmol; 2012 Nov; 154(5):865-871.e1. PubMed ID: 22840480
[TBL] [Abstract][Full Text] [Related]
8. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy.
Canakis C; Livir-Rallatos C; Panayiotis Z; Livir-Rallatos G; Persidis E; Conway MD; Peyman GA
Am J Ophthalmol; 2003 Oct; 136(4):750-2. PubMed ID: 14516825
[TBL] [Abstract][Full Text] [Related]
9. [Photodynamic therapy for chronic central serous chorioretinopathy and diffuse retinal epitheliopathy].
Cornut PL; Quaranta-El Maftouhi M; Mauget-Faÿsse M
J Fr Ophtalmol; 2012 Feb; 35(2):82-7. PubMed ID: 21889817
[TBL] [Abstract][Full Text] [Related]
10. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy.
Arif F; Pryds A; Larsen M
Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489
[TBL] [Abstract][Full Text] [Related]
11. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Cheng CK; Chang CK; Peng CH
Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
[TBL] [Abstract][Full Text] [Related]
12. Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy.
Reibaldi M; Boscia F; Avitabile T; Russo A; Cannemi V; Uva MG; Reibaldi A
Eur J Ophthalmol; 2009; 19(1):154-8. PubMed ID: 19123167
[TBL] [Abstract][Full Text] [Related]
13. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.
Lai TY; Chan WM; Li H; Lai RY; Liu DT; Lam DS
Br J Ophthalmol; 2006 Jul; 90(7):869-74. PubMed ID: 16597666
[TBL] [Abstract][Full Text] [Related]
14. Acute retinal pigment epithelial tear after photodynamic therapy.
Pece A; Introini U; Bottoni F; Brancato R
Retina; 2001; 21(6):661-5. PubMed ID: 11756893
[No Abstract] [Full Text] [Related]
15. Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results.
Fujita K; Yuzawa M; Mori R
Retina; 2011 Apr; 31(4):772-8. PubMed ID: 20890236
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy with verteporfin for avascular serous pigment epithelial detachment in elderly Koreans.
Kim KS; Lee WK
Retina; 2010 Jan; 30(1):93-9. PubMed ID: 19696702
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for chronic pigment epithelial detachment in central serous chorioretinopathy.
Chang MA; Bressler SB
Can J Ophthalmol; 2009 Apr; 44(2):221-2. PubMed ID: 19491970
[No Abstract] [Full Text] [Related]
18. Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy.
Lee PY; Kim KS; Lee WK
Jpn J Ophthalmol; 2009 Jan; 53(1):52-56. PubMed ID: 19184311
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy.
Moon JW; Yu HG; Kim TW; Kim HC; Chung H
Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1315-23. PubMed ID: 19421764
[TBL] [Abstract][Full Text] [Related]
20. One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Hashizume K; Mizota A; Yuzawa M
Ophthalmology; 2015 Mar; 122(3):555-61. PubMed ID: 25444637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
